Significant improvements in physical examination findings and bone marrow aspirates of DM with allo-HCT. (A) Bone marrow aspirate prior to chemotherapy (1000× magnification, Wright-Giemsa stain): MDS with excess blasts-2 (MDS:EB2). Blue arrow, myeloblast; black arrow, hypogranular neutrophil; yellow arrow, proerythroblast. (B) Dermatologic findings prior to beginning chemotherapy (C), following 3 cycles of chemotherapy (D), following 6 cycles of chemotherapy and prior to allo-HCT (E), and 8 weeks following allo-HCT. (F) Bone marrow aspirate post–allo-HCT (1000× magnification, Wright-Giemsa stain): normal morphology for granulocytes and erythroid precursors.